Cite
HARVARD Citation
Lee, A. et al. (2015). UK AMD EMR USERS GROUP REPORT V: benefits of initiating ranibizumab therapy for neovascular AMD in eyes with vision better than 6/12. British journal of ophthalmology. 99 (8), pp. 1045-1050. [Online].